EXPERIMENTAL CELL RESEARCH

简称 EXP CELL RES ·UNITED STATES ·出版周期 Semimonthly ·年均收录 287 篇

3.5

最新影响因子

2.40%

自引率

约80%

投稿难度

平均2月来源Elsevier官网：平…

审稿周期

期刊简介

EXPERIMENTAL CELL RESEARCH是一本国际学术期刊，ISSN号为0014-4827，由Elsevier出版社出版，出版地为荷兰，出版周期为月刊。该期刊的影响因子根据年份有所不同，近年大约在3.5至4.0之间，属于SCI收录期刊，中科院分区通常位于生物学大类的3区或4区。该期刊为非OA（开放获取）期刊，但提供OA选项。其发文特点主要集中在细胞生物学领域，涵盖细胞结构、功能、代谢、信号传导、细胞周期、凋亡、分化以及癌症细胞生物学等研究方向，尤其关注实验性研究和技术创新。杂志的质量较高，审稿流程严格，但近年来因竞争激烈，投稿难度有所增加，可能存在发表周期较长或拒稿率较高的风险。总体而言，该期刊适合发表具有创新性和实验支持的细胞生物学研究成果。

影响因子趋势

近期发表

AMPK-YAP/TAZ signaling pathway mediates the amelioration of endothelial dysfunction elicited by moderate-intensity exercise-induced wall shear stress 2026-08-29

CTSB promotes ferroptosis in macrophage-derived foam cells and aggravates plaque instability via the NRF2/HMOX1 axis 2026-08-14

PRDM5 regulates ASK1 transcription to affect macrophage inflammation, lipid accumulation and apoptosis progression 2026-08-19

Enhancer collapse dictates PKHD1 silencing and centrosome-mediated chromosomal instability and metastasis in clear cell renal cell carcinoma 2026-08-12

Role of the MALAT1-Importin 7-HIF1A regulatory axis in the progression of cutaneous squamous cell carcinoma 2026-08-31

Targeting the ubiquitin-proteasome system: An emerging paradigm for overcoming resistance to targeted therapy in non-small cell lung cancer 2026-08-13

CircUBE2I regulates YAP/TAZ signaling pathway through miR-659-3p/PSMA1 axis to promote human lung adenocarcinoma cell progression 2026-08-18

IRF8 transcriptionally drives NAIP to promote NLRP3/NLRC4 inflammasome-mediated renal tubular pyroptosis in diabetic kidney disease 2026-08-18

Engineered exosomes for CRISPR/Cas delivery to overcome oncogene-driven drug resistance 2026-08-28

Squalene epoxidase in cancer: Mechanistic insights, therapeutic potential, and future perspectives 2026-08-28